The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Research Report 2025
Synopsis
The global Autologous Stem Cell and Non-Stem Cell Based Therapies market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Autologous Stem Cell and Non-Stem Cell Based Therapies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autologous Stem Cell and Non-Stem Cell Based Therapies.
Report Scope
The Autologous Stem Cell and Non-Stem Cell Based Therapies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Autologous Stem Cell and Non-Stem Cell Based Therapies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Autologous Stem Cell and Non-Stem Cell Based Therapies companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Fibrocell Science, Inc.
Vericel Corporation
Dendreon Corporation (Sanpower Group)
Caladrius Biosciences, Inc.
BrainStorm Cell Therapeutics
Regeneus Ltd.
Genzyme Corporation
Pluristem Therapeutics Inc
U.S. Stem Cell, Inc
TiGenix (Takeda)
Segment by Type
Autologous Stem Cell Therapy
Non-Stem Cell Therapy
Segment by Application
Cancer
Neurodegenerative Disorders
Cardiovascular Disease
Autoimmune Diseases
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Autologous Stem Cell and Non-Stem Cell Based Therapies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Autologous Stem Cell and Non-Stem Cell Based Therapies market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Autologous Stem Cell and Non-Stem Cell Based Therapies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autologous Stem Cell and Non-Stem Cell Based Therapies.
Report Scope
The Autologous Stem Cell and Non-Stem Cell Based Therapies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Autologous Stem Cell and Non-Stem Cell Based Therapies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Autologous Stem Cell and Non-Stem Cell Based Therapies companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Fibrocell Science, Inc.
Vericel Corporation
Dendreon Corporation (Sanpower Group)
Caladrius Biosciences, Inc.
BrainStorm Cell Therapeutics
Regeneus Ltd.
Genzyme Corporation
Pluristem Therapeutics Inc
U.S. Stem Cell, Inc
TiGenix (Takeda)
Segment by Type
Autologous Stem Cell Therapy
Non-Stem Cell Therapy
Segment by Application
Cancer
Neurodegenerative Disorders
Cardiovascular Disease
Autoimmune Diseases
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Autologous Stem Cell and Non-Stem Cell Based Therapies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Autologous Stem Cell Therapy
1.2.3 Non-Stem Cell Therapy
1.3 Market by Application
1.3.1 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cancer
1.3.3 Neurodegenerative Disorders
1.3.4 Cardiovascular Disease
1.3.5 Autoimmune Diseases
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Perspective (2019-2030)
2.2 Autologous Stem Cell and Non-Stem Cell Based Therapies Growth Trends by Region
2.2.1 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Autologous Stem Cell and Non-Stem Cell Based Therapies Historic Market Size by Region (2019-2024)
2.2.3 Autologous Stem Cell and Non-Stem Cell Based Therapies Forecasted Market Size by Region (2025-2030)
2.3 Autologous Stem Cell and Non-Stem Cell Based Therapies Market Dynamics
2.3.1 Autologous Stem Cell and Non-Stem Cell Based Therapies Industry Trends
2.3.2 Autologous Stem Cell and Non-Stem Cell Based Therapies Market Drivers
2.3.3 Autologous Stem Cell and Non-Stem Cell Based Therapies Market Challenges
2.3.4 Autologous Stem Cell and Non-Stem Cell Based Therapies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Autologous Stem Cell and Non-Stem Cell Based Therapies Players by Revenue
3.1.1 Global Top Autologous Stem Cell and Non-Stem Cell Based Therapies Players by Revenue (2019-2024)
3.1.2 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue Market Share by Players (2019-2024)
3.2 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue
3.4 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Concentration Ratio
3.4.1 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue in 2023
3.5 Autologous Stem Cell and Non-Stem Cell Based Therapies Key Players Head office and Area Served
3.6 Key Players Autologous Stem Cell and Non-Stem Cell Based Therapies Product Solution and Service
3.7 Date of Enter into Autologous Stem Cell and Non-Stem Cell Based Therapies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Autologous Stem Cell and Non-Stem Cell Based Therapies Breakdown Data by Type
4.1 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Historic Market Size by Type (2019-2024)
4.2 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Forecasted Market Size by Type (2025-2030)
5 Autologous Stem Cell and Non-Stem Cell Based Therapies Breakdown Data by Application
5.1 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Historic Market Size by Application (2019-2024)
5.2 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size (2019-2030)
6.2 North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2019-2024)
6.4 North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size (2019-2030)
7.2 Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2019-2024)
7.4 Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size (2019-2030)
8.2 Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Region (2019-2024)
8.4 Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size (2019-2030)
9.2 Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2019-2024)
9.4 Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size (2019-2030)
10.2 Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2019-2024)
10.4 Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Fibrocell Science, Inc.
11.1.1 Fibrocell Science, Inc. Company Detail
11.1.2 Fibrocell Science, Inc. Business Overview
11.1.3 Fibrocell Science, Inc. Autologous Stem Cell and Non-Stem Cell Based Therapies Introduction
11.1.4 Fibrocell Science, Inc. Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2019-2024)
11.1.5 Fibrocell Science, Inc. Recent Development
11.2 Vericel Corporation
11.2.1 Vericel Corporation Company Detail
11.2.2 Vericel Corporation Business Overview
11.2.3 Vericel Corporation Autologous Stem Cell and Non-Stem Cell Based Therapies Introduction
11.2.4 Vericel Corporation Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2019-2024)
11.2.5 Vericel Corporation Recent Development
11.3 Dendreon Corporation (Sanpower Group)
11.3.1 Dendreon Corporation (Sanpower Group) Company Detail
11.3.2 Dendreon Corporation (Sanpower Group) Business Overview
11.3.3 Dendreon Corporation (Sanpower Group) Autologous Stem Cell and Non-Stem Cell Based Therapies Introduction
11.3.4 Dendreon Corporation (Sanpower Group) Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2019-2024)
11.3.5 Dendreon Corporation (Sanpower Group) Recent Development
11.4 Caladrius Biosciences, Inc.
11.4.1 Caladrius Biosciences, Inc. Company Detail
11.4.2 Caladrius Biosciences, Inc. Business Overview
11.4.3 Caladrius Biosciences, Inc. Autologous Stem Cell and Non-Stem Cell Based Therapies Introduction
11.4.4 Caladrius Biosciences, Inc. Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2019-2024)
11.4.5 Caladrius Biosciences, Inc. Recent Development
11.5 BrainStorm Cell Therapeutics
11.5.1 BrainStorm Cell Therapeutics Company Detail
11.5.2 BrainStorm Cell Therapeutics Business Overview
11.5.3 BrainStorm Cell Therapeutics Autologous Stem Cell and Non-Stem Cell Based Therapies Introduction
11.5.4 BrainStorm Cell Therapeutics Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2019-2024)
11.5.5 BrainStorm Cell Therapeutics Recent Development
11.6 Regeneus Ltd.
11.6.1 Regeneus Ltd. Company Detail
11.6.2 Regeneus Ltd. Business Overview
11.6.3 Regeneus Ltd. Autologous Stem Cell and Non-Stem Cell Based Therapies Introduction
11.6.4 Regeneus Ltd. Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2019-2024)
11.6.5 Regeneus Ltd. Recent Development
11.7 Genzyme Corporation
11.7.1 Genzyme Corporation Company Detail
11.7.2 Genzyme Corporation Business Overview
11.7.3 Genzyme Corporation Autologous Stem Cell and Non-Stem Cell Based Therapies Introduction
11.7.4 Genzyme Corporation Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2019-2024)
11.7.5 Genzyme Corporation Recent Development
11.8 Pluristem Therapeutics Inc
11.8.1 Pluristem Therapeutics Inc Company Detail
11.8.2 Pluristem Therapeutics Inc Business Overview
11.8.3 Pluristem Therapeutics Inc Autologous Stem Cell and Non-Stem Cell Based Therapies Introduction
11.8.4 Pluristem Therapeutics Inc Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2019-2024)
11.8.5 Pluristem Therapeutics Inc Recent Development
11.9 U.S. Stem Cell, Inc
11.9.1 U.S. Stem Cell, Inc Company Detail
11.9.2 U.S. Stem Cell, Inc Business Overview
11.9.3 U.S. Stem Cell, Inc Autologous Stem Cell and Non-Stem Cell Based Therapies Introduction
11.9.4 U.S. Stem Cell, Inc Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2019-2024)
11.9.5 U.S. Stem Cell, Inc Recent Development
11.10 TiGenix (Takeda)
11.10.1 TiGenix (Takeda) Company Detail
11.10.2 TiGenix (Takeda) Business Overview
11.10.3 TiGenix (Takeda) Autologous Stem Cell and Non-Stem Cell Based Therapies Introduction
11.10.4 TiGenix (Takeda) Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2019-2024)
11.10.5 TiGenix (Takeda) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Autologous Stem Cell Therapy
Table 3. Key Players of Non-Stem Cell Therapy
Table 4. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Region (2019-2024)
Table 8. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Region (2025-2030)
Table 10. Autologous Stem Cell and Non-Stem Cell Based Therapies Market Trends
Table 11. Autologous Stem Cell and Non-Stem Cell Based Therapies Market Drivers
Table 12. Autologous Stem Cell and Non-Stem Cell Based Therapies Market Challenges
Table 13. Autologous Stem Cell and Non-Stem Cell Based Therapies Market Restraints
Table 14. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Players (2019-2024)
Table 16. Global Top Autologous Stem Cell and Non-Stem Cell Based Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies as of 2023)
Table 17. Ranking of Global Top Autologous Stem Cell and Non-Stem Cell Based Therapies Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Autologous Stem Cell and Non-Stem Cell Based Therapies Product Solution and Service
Table 21. Date of Enter into Autologous Stem Cell and Non-Stem Cell Based Therapies Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue Market Share by Type (2019-2024)
Table 25. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue Market Share by Type (2025-2030)
Table 27. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue Market Share by Application (2019-2024)
Table 29. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue Market Share by Application (2025-2030)
Table 31. North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2025-2030) & (US$ Million)
Table 46. Fibrocell Science, Inc. Company Detail
Table 47. Fibrocell Science, Inc. Business Overview
Table 48. Fibrocell Science, Inc. Autologous Stem Cell and Non-Stem Cell Based Therapies Product
Table 49. Fibrocell Science, Inc. Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2019-2024) & (US$ Million)
Table 50. Fibrocell Science, Inc. Recent Development
Table 51. Vericel Corporation Company Detail
Table 52. Vericel Corporation Business Overview
Table 53. Vericel Corporation Autologous Stem Cell and Non-Stem Cell Based Therapies Product
Table 54. Vericel Corporation Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2019-2024) & (US$ Million)
Table 55. Vericel Corporation Recent Development
Table 56. Dendreon Corporation (Sanpower Group) Company Detail
Table 57. Dendreon Corporation (Sanpower Group) Business Overview
Table 58. Dendreon Corporation (Sanpower Group) Autologous Stem Cell and Non-Stem Cell Based Therapies Product
Table 59. Dendreon Corporation (Sanpower Group) Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2019-2024) & (US$ Million)
Table 60. Dendreon Corporation (Sanpower Group) Recent Development
Table 61. Caladrius Biosciences, Inc. Company Detail
Table 62. Caladrius Biosciences, Inc. Business Overview
Table 63. Caladrius Biosciences, Inc. Autologous Stem Cell and Non-Stem Cell Based Therapies Product
Table 64. Caladrius Biosciences, Inc. Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2019-2024) & (US$ Million)
Table 65. Caladrius Biosciences, Inc. Recent Development
Table 66. BrainStorm Cell Therapeutics Company Detail
Table 67. BrainStorm Cell Therapeutics Business Overview
Table 68. BrainStorm Cell Therapeutics Autologous Stem Cell and Non-Stem Cell Based Therapies Product
Table 69. BrainStorm Cell Therapeutics Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2019-2024) & (US$ Million)
Table 70. BrainStorm Cell Therapeutics Recent Development
Table 71. Regeneus Ltd. Company Detail
Table 72. Regeneus Ltd. Business Overview
Table 73. Regeneus Ltd. Autologous Stem Cell and Non-Stem Cell Based Therapies Product
Table 74. Regeneus Ltd. Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2019-2024) & (US$ Million)
Table 75. Regeneus Ltd. Recent Development
Table 76. Genzyme Corporation Company Detail
Table 77. Genzyme Corporation Business Overview
Table 78. Genzyme Corporation Autologous Stem Cell and Non-Stem Cell Based Therapies Product
Table 79. Genzyme Corporation Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2019-2024) & (US$ Million)
Table 80. Genzyme Corporation Recent Development
Table 81. Pluristem Therapeutics Inc Company Detail
Table 82. Pluristem Therapeutics Inc Business Overview
Table 83. Pluristem Therapeutics Inc Autologous Stem Cell and Non-Stem Cell Based Therapies Product
Table 84. Pluristem Therapeutics Inc Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2019-2024) & (US$ Million)
Table 85. Pluristem Therapeutics Inc Recent Development
Table 86. U.S. Stem Cell, Inc Company Detail
Table 87. U.S. Stem Cell, Inc Business Overview
Table 88. U.S. Stem Cell, Inc Autologous Stem Cell and Non-Stem Cell Based Therapies Product
Table 89. U.S. Stem Cell, Inc Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2019-2024) & (US$ Million)
Table 90. U.S. Stem Cell, Inc Recent Development
Table 91. TiGenix (Takeda) Company Detail
Table 92. TiGenix (Takeda) Business Overview
Table 93. TiGenix (Takeda) Autologous Stem Cell and Non-Stem Cell Based Therapies Product
Table 94. TiGenix (Takeda) Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2019-2024) & (US$ Million)
Table 95. TiGenix (Takeda) Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Type: 2023 VS 2030
Figure 3. Autologous Stem Cell Therapy Features
Figure 4. Non-Stem Cell Therapy Features
Figure 5. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Application: 2023 VS 2030
Figure 7. Cancer Case Studies
Figure 8. Neurodegenerative Disorders Case Studies
Figure 9. Cardiovascular Disease Case Studies
Figure 10. Autoimmune Diseases Case Studies
Figure 11. Others Case Studies
Figure 12. Autologous Stem Cell and Non-Stem Cell Based Therapies Report Years Considered
Figure 13. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Region: 2023 VS 2030
Figure 16. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Players in 2023
Figure 17. Global Top Autologous Stem Cell and Non-Stem Cell Based Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue in 2023
Figure 19. North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Country (2019-2030)
Figure 21. United States Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Country (2019-2030)
Figure 25. Germany Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Region (2019-2030)
Figure 33. China Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Country (2019-2030)
Figure 41. Mexico Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Country (2019-2030)
Figure 45. Turkey Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Fibrocell Science, Inc. Revenue Growth Rate in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2019-2024)
Figure 48. Vericel Corporation Revenue Growth Rate in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2019-2024)
Figure 49. Dendreon Corporation (Sanpower Group) Revenue Growth Rate in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2019-2024)
Figure 50. Caladrius Biosciences, Inc. Revenue Growth Rate in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2019-2024)
Figure 51. BrainStorm Cell Therapeutics Revenue Growth Rate in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2019-2024)
Figure 52. Regeneus Ltd. Revenue Growth Rate in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2019-2024)
Figure 53. Genzyme Corporation Revenue Growth Rate in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2019-2024)
Figure 54. Pluristem Therapeutics Inc Revenue Growth Rate in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2019-2024)
Figure 55. U.S. Stem Cell, Inc Revenue Growth Rate in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2019-2024)
Figure 56. TiGenix (Takeda) Revenue Growth Rate in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2019-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
